`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________
`
`
`
`
`WOCKHARDT BIO AG,
`Petitioner
`v.
`JANSSEN ONCOLOGY, INC.,
`Patent Owner
`____________________________
`
`Case IPR: 2016-01582
`U.S. Patent No. 8,822,438
`____________________________
`
`SUPPLEMENTAL DECLARATION OF
`DECLARATION OF PAUL A. GODLEY, M.D., Ph.D., MPP
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`-i-
`
`WCK1123
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`
`
`
`
`
`I, Paul A. Godley, declare as follows:
`
`1.
`
`I am the same Paul A. Godley who executed a declaration on
`
`August 10, 2016 (WCK1002) and a second declaration on April 14, 2017
`
`(WCK1104) in this inter partes review proceeding, IPR2016-01582.
`
`2.
`
`I understand from counsel that Patent Owner raised certain issues
`
`with my second declaration executed on April 14, 2017, and certain exhibits cited
`
`therein in Patent Owner’s Objections to Evidence Under 37 C.F.R. § 42.64(b)(1)
`
`dated April 26, 2017. I submit this supplemental declaration to address the issues
`
`asserted by Patent Owner in its objections.
`
`3.
`
`I understand that Janssen objected to several exhibits cited in my
`
`second declaration—specifically, Exhibits 1090, 1091, 1092, and 1094. I
`
`understand that Janssen asserted that Petitioner Wockhardt’s ("Wockhardt") Reply
`
`and my second declaration did not establish the origin of those documents or that
`
`the documents are a true and correct copy of what they purport to be and hence
`
`inauthentic, or that the documents are either incomplete, improper or irrelevant. I
`
`disagree with Janssen’s assertions and, in response, submit this supplemental
`
`declaration.
`
`4.
`
` To address Petitioner’s objections, I will confirm that to the best
`
`of my knowledge the exhibits cited in my initial declaration—including Exhibits
`
`1090, 1091, 1092, and 1094—are true and accurate copies of what they purport to
`
`- 1 -
`
`WCK1123
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`be, and that an expert in the field would reasonably rely on them to formulate
`
`
`
`
`
`opinions such as those set forth in my initial and second declarations.
`
`5. WCK1094 is a true and correct copy of a document that I
`
`downloaded on April 6, 2017 from the ASCO University’s Meeting Library page:
`
`http://meetinglibrary.asco.org/
`
`6. WCK1091, WCK1092, and WCK1094 are documents that are
`
`relevant to the opinions that I have formulated in my initial and second
`
`declarations, and are documents that an expert in the field would reasonably rely
`
`on to formulate said opinions.
`
`7.
`
`I understand from counsel that Janssen objected to WCK1090
`
`cited in my second declaration for allegedly being incomplete. I have supplied
`
`the entirety of WCK1090 in this proceeding as an attachment to this
`
`supplemental Declaration.
`
`8.
`
`I declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements were made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under Section 1001 of Title 18 of the United States Code.
`
`- 2 -
`
`
`
`WCK1123
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`
`
`Executed this 2nd day of May 2017.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`Dr. Paul A. Godley, M.D., Ph.D, MPP
`
`
`
`
`
`
`
`
`
`- 3 -
`
`WCK1123
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`